RxNorm Semantic Concepts Index - 184
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "184".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 18404 | Carbohydrate deficient transferrin, asialo fraction | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18404 | Carbohydrate deficient transferrin, asialo fraction | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18404 | Carbohydrate deficient transferrin, asialo fraction | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18405 | asiaticoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 184067 | Chenodeoxycholoyltaurine hydrolase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 184067 | Chenodeoxycholoyltaurine hydrolase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1841 | Butorphanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1841 | Butorphanol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1841 | Butorphanol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1841 | Butorphanol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1841 | Butorphanol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 18415 | Asparagine-oxo-acid aminotransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18415 | Asparagine-oxo-acid aminotransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18417 | Asparagusate dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18417 | Asparagusate dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18417 | Asparagusate dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18417 | Asparagusate dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18421 | Desulfinase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18421 | Desulfinase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18421 | Desulfinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18421 | Desulfinase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18422 | Aspartate aminopeptidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18422 | Aspartate aminopeptidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18422 | Aspartate aminopeptidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18423 | Aspartate carboxypeptidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18423 | Aspartate carboxypeptidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18425 | Aspartate racemase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18425 | Aspartate racemase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18426 | Aspartate alpha-decarboxylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18426 | Aspartate alpha-decarboxylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18426 | Aspartate alpha-decarboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1843 | Butter | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1843 | Butter | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18432 | Aminoacylase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18432 | Aminoacylase II | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18432 | Aminoacylase II | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18451 | astaxanthin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 184557 | Progesterone 11alpha-hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 184557 | Progesterone 11alpha-hydroxylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 184557 | Progesterone 11alpha-hydroxylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18469 | sparfloxacin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18469 | sparfloxacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 18469 | sparfloxacin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18469 | sparfloxacin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18469 | sparfloxacin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18475 | atipamezole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 18475 | atipamezole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 18475 | atipamezole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1848 | 2,6-di-tert-butyl-p-cresol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 18482 | Protease Ti | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18482 | Protease Ti | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18482 | Protease Ti | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18482 | Protease Ti | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18493 | Atranorin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18493 | Atranorin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18493 | Atranorin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18493 | Atranorin | Full form of descriptor (FN) | NO |